Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianliebao granules for chronic prostatitis (phase II, placebo-controlled)
CTR20132005Phase 2Completed
- Sponsor
- Guangdong Kangping Pharmaceutical Innovation Technology Development
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qianliebao in chronic prostatitis (CP), sponsored by Guangdong Kangping Pharmaceutical Innovation Technology Development. Started Aug 2014; status: completed.
02
Drugs
Qianliebao
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20132005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132005.